Stryker Ebitda from 2010 to 2024

SYK Stock  USD 357.87  0.84  0.23%   
Stryker EBITDA yearly trend continues to be quite stable with very little volatility. EBITDA may rise above about 5.2 B this year. From the period between 2010 and 2024, Stryker, EBITDA regression line of its data series had standard deviation of  1,341,194,910 and standard deviation of  1,341,194,910. View All Fundamentals
 
EBITDA  
First Reported
1985-09-30
Previous Quarter
1.2 B
Current Value
1.5 B
Quarterly Volatility
365.4 M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Stryker financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Stryker main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 B, Interest Expense of 373.8 M or Total Revenue of 21.5 B, as well as many exotic indicators such as Short Term Coverage Ratios of 1.68, Price Earnings Ratio of 48.53 or Price To Sales Ratio of 2.98. Stryker financial statements analysis is a perfect complement when working with Stryker Valuation or Volatility modules.
  
This module can also supplement Stryker's financial leverage analysis and stock options assessment as well as various Stryker Technical models . Check out the analysis of Stryker Correlation against competitors.
For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.

Latest Stryker's Ebitda Growth Pattern

Below is the plot of the Ebitda of Stryker over the last few years. It is Stryker's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Stryker's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Stryker Ebitda Regression Statistics

Arithmetic Mean3,038,286,667
Geometric Mean2,173,158,346
Coefficient Of Variation44.14
Mean Deviation985,907,556
Median3,069,000,000
Standard Deviation1,341,194,910
Sample Variance1798803.8T
Range5.2B
R-Value0.91
Mean Square Error327507.7T
R-Squared0.83
Slope273,376,071
Total Sum of Squares25183253T

Stryker Ebitda History

20245.2 B
2023B
20224.2 B
20213.8 B
20203.1 B
20193.9 B
20183.3 B

About Stryker Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Stryker income statement, its balance sheet, and the statement of cash flows. Stryker investors use historical funamental indicators, such as Stryker's Ebitda, to determine how well the company is positioned to perform in the future. Although Stryker investors may use each financial statement separately, they are all related. The changes in Stryker's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Stryker's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Stryker Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Stryker. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
EBITDAB5.2 B

Currently Active Assets on Macroaxis

When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:
Check out the analysis of Stryker Correlation against competitors.
For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Stryker Stock analysis

When running Stryker's price analysis, check to measure Stryker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stryker is operating at the current time. Most of Stryker's value examination focuses on studying past and present price action to predict the probability of Stryker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stryker's price. Additionally, you may evaluate how the addition of Stryker to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Is Stryker's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.027
Dividend Share
3.05
Earnings Share
8.25
Revenue Per Share
53.999
Quarterly Revenue Growth
0.118
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.